Pow.Bio

The company's core business revolves around a 'fermentation as a service' model, providing intelligent biomanufacturing services to a diverse clientele that includes startups and established multinational corporations in the food, agriculture, chemical, and materials sectors. Pow.Bio's revenue is generated by helping companies validate microbial strains, optimize production processes, and manufacture materials for testing and initial market entry. The long-term business model includes licensing its technology for integration into clients' own facilities or at contract manufacturing sites, facilitating a capital-light conversion of existing infrastructure.

Pow.Bio's key offering is an advanced continuous fermentation platform that challenges the traditional, capital-intensive batch fermentation process. This proprietary system utilizes a two-chamber bioreactor that separates the microbial growth phase from the production phase. This decoupling allows microbes to be maintained in a highly productive state for weeks, mitigating common issues of contamination and genetic drift that have historically hindered continuous biomanufacturing. Integrated with an AI-driven software platform called SOFe (Self-Optimizing Fermentor), the system enables rapid process optimization—in weeks rather than months—and predictive, autonomous control. This results in significant productivity gains, reportedly 2 to 5 times greater output, and cost reductions of up to 70% compared to conventional methods. In March 2025, the company opened a 25,000-square-foot, FDA-registered demonstration facility in Alameda, California, to showcase these capabilities and produce materials from gram-scale up to hundreds of kilograms.